Literature DB >> 23105285

An overview of monoclonal gammapathies.

T Malati1.   

Abstract

The neoplastic proliferation of single clones of plasma cells causes synthesis of very large amount of monoclonal immunoglobulins consisting of only one type of heavy either the gamma, alpha, mu, delta or epsilon chain or only kappa or lambda light chains. Each monoclonal immunolobulin differs idiotypically from each other. These monoclonal immunoglobulins are also called paraproteins and are frequently associated with a broad heterogeneous group of plasma cell dyscrasias. Occasionally their presence is observed in a few benign conditions and in old age. In the present review a detailed account of different types of monoclonal gammapathies are described.

Entities:  

Keywords:  Monoclonal gammapathies; cancer M proteins; monoclonal immunoglobulins; myeloma proteins; paraproteins

Year:  2001        PMID: 23105285      PMCID: PMC3453611          DOI: 10.1007/BF02867561

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  57 in total

1.  The incidence of myelomatosis.

Authors:  N H MARTIN
Journal:  Lancet       Date:  1961-02-04       Impact factor: 79.321

2.  A noncryo-monoclonal IgM with auto anti-IgG activity in a case of lymphosarcoma.

Authors:  R M Gupta; T Malati; M Chakarvarty
Journal:  Indian J Med Res       Date:  1978-05       Impact factor: 2.375

3.  Monoclonal IgA and IgM in the serum of a single patient (SC). I. Sharing of individually specific determinants between IgA and IgM.

Authors:  Y Yagi; D Pressman
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

4.  Transient paraproteins.

Authors:  V H Young
Journal:  Proc R Soc Med       Date:  1969-08

5.  Cryoglobulinemia--a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability.

Authors:  M Meltzer; E C Franklin
Journal:  Am J Med       Date:  1966-06       Impact factor: 4.965

6.  Multiple myeloma and acute myelomonocytic leukemia.

Authors:  R A Kyle; R V Pierre; E D Bayrd
Journal:  N Engl J Med       Date:  1970-11-19       Impact factor: 91.245

7.  Clinical features and outcome of multiple myeloma arising from the transformation of a monoclonal gammapathy of undetermined significance.

Authors:  F Patriarca; R Fanin; F Silvestri; A Candoni; F Zaja; A Sperotto; A Geromin; M Baccarani
Journal:  Leuk Lymphoma       Date:  1999-08

8.  M components associated with lymphoma: a review of 62 cases.

Authors:  H S Ko; W Pruzanski
Journal:  Am J Med Sci       Date:  1976 Sep-Oct       Impact factor: 2.378

9.  Multiple myeloma in the United States, 1950--1975.

Authors:  W A Blattner; A Blair; T J Mason
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

10.  Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics.

Authors:  R García-Sanz; A Orfão; M González; M D Tabernero; J Bladé; M J Moro; J Fernández-Calvo; M A Sanz; J A Pérez-Simón; A Rasillo; J F Miguel
Journal:  Blood       Date:  1999-02-01       Impact factor: 22.113

View more
  1 in total

1.  Tumour markers: An overview.

Authors:  T Malati
Journal:  Indian J Clin Biochem       Date:  2007-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.